🇺🇸 FDA
Pipeline program

Febuxostat

2024JD0925

Unknown small_molecule active

Quick answer

Febuxostat for Refractory Gout is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Refractory Gout
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials